Texas Medical Center
Address
6621 Fannin Street
Suite AB1195
Houston, TX 77030
Adekunle Michael Adesina, MD, PhD
Medical Director of Neuropathology, Molecular Neuropathology and Global Pathology
Texas Children's Hospital
Professor of Pathology & Immunology and Pediatrics, Baylor College of Medicine
Education
| School | Education | Degree | Year |
|---|---|---|---|
| McGill University, Montreal, Canada | PhD | Doctor of Philosophy | 1997 |
| Fox Chase Cancer Center | Residency | Pathology | 1994 |
| McGill University Faculty of Medicine | Professional Education | Molecular & Human Genetics | 1992 |
| Montreal General Hospital-Canada | Fellowship | Research Fellowship | 1992 |
| Albert-Ludwigs University | Fellowship | 1991 | |
| University of Vermont | Residency | Pathology | 1990 |
| University of Ibadan | Residency | Anatomic Pathology | 1986 |
| University of Ibadan | Internship | Senior House Officer | 1981 |
| University of Ibadan | Medical School | Bachelor of Medicine & Surgery | 1980 |
About
Dr. Adesina's primary interest is in the clinical and molecular genetics of pediatric brain tumors with special interest in medulloblastoma. He is involved in ongoing collaborative studies with the pediatric brain tumor group of the Hematology/Oncology division. He is also a collaborator with others on the genomic profiling of embryonal pediatric tumors and the role of FoxG1 in determining susceptibility to these embryonal tumors.
Organizations
| Organization Name | Role |
|---|---|
| American Association for the Advancement of Science | Member |
| American Association of Neuropathologists | Member |
| Anatomic Pathology and Molecular Pathology, College of American Pathologists | Inspector |
| Association for Molecular Pathology | Member |
| College of American Pathologists and Archives of Pathology and Laboratory Medicine | Associate Editor |
Selected Publications
Li JY, Langford LA, Adesina A, Bodhireddy SR, Wang M, Fuller GN. The high mitotic count detected by phospho-histone H3 immunostain does not alter the benign behavior of angiocentric glioma. Brain Tumor Pathology 2012 Jan;29(1):68-72.
* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.